97 related articles for article (PubMed ID: 27576133)
1. Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56α subunit.
Kawashima I; Kirito K
Exp Hematol; 2016 Dec; 44(12):1156-1165.e4. PubMed ID: 27576133
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.
Mitsumori T; Nozaki Y; Kawashima I; Yamamoto T; Shobu Y; Nakajima K; Morishita S; Komatsu N; Kirito K
Exp Hematol; 2014 Sep; 42(9):783-92.e1. PubMed ID: 24860972
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
5. PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.
Ruvolo VR; Kurinna SM; Karanjeet KB; Schuster TF; Martelli AM; McCubrey JA; Ruvolo PP
J Biol Chem; 2008 Dec; 283(51):35474-85. PubMed ID: 18957415
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
[TBL] [Abstract][Full Text] [Related]
7. B56α subunit of protein phosphatase 2A mediates retinoic acid-induced decreases in phosphorylation of endothelial nitric oxide synthase at serine 1179 and nitric oxide production in bovine aortic endothelial cells.
Park JH; Sung HY; Lee JY; Kim HJ; Ahn JH; Jo I
Biochem Biophys Res Commun; 2013 Jan; 430(2):476-81. PubMed ID: 23237802
[TBL] [Abstract][Full Text] [Related]
8. PP2A catalytic subunit silence by microRNA-429 activates AMPK and protects osteoblastic cells from dexamethasone.
Guo S; Chen C; Ji F; Mao L; Xie Y
Biochem Biophys Res Commun; 2017 Jun; 487(3):660-665. PubMed ID: 28438603
[TBL] [Abstract][Full Text] [Related]
9. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
10. PP2A-AMPKα-HSF1 axis regulates the metal-inducible expression of HSPs and ROS clearance.
Zhu XN; Chen LP; Bai Q; Ma L; Li DC; Zhang JM; Gao C; Lei ZN; Zhang ZB; Xing XM; Liu CX; He ZN; Li J; Xiao YM; Zhang AH; Zeng XW; Chen W
Cell Signal; 2014 Apr; 26(4):825-32. PubMed ID: 24412756
[TBL] [Abstract][Full Text] [Related]
11. The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation.
Reid MA; Wang WI; Rosales KR; Welliver MX; Pan M; Kong M
Mol Cell; 2013 Apr; 50(2):200-11. PubMed ID: 23499005
[TBL] [Abstract][Full Text] [Related]
12. Effects of Ruxolitinib on Myeloproliferative Neoplasms via the Negative Regulators.
Wang SY; Xie XL; Liang JY; Cheng ZY
Clin Lab; 2023 Feb; 69(2):. PubMed ID: 36787550
[TBL] [Abstract][Full Text] [Related]
13. A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth.
Plews RL; Mohd Yusof A; Wang C; Saji M; Zhang X; Chen CS; Ringel MD; Phay JE
J Clin Endocrinol Metab; 2015 May; 100(5):E748-56. PubMed ID: 25710562
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumour effect of metformin in canine mammary gland tumour cells.
Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
[TBL] [Abstract][Full Text] [Related]
15. Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56
Tang Y; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z
Biomed Res Int; 2019; 2019():2582401. PubMed ID: 31641668
[TBL] [Abstract][Full Text] [Related]
16. TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.
Pardanani A; Hood J; Lasho T; Levine RL; Martin MB; Noronha G; Finke C; Mak CC; Mesa R; Zhu H; Soll R; Gilliland DG; Tefferi A
Leukemia; 2007 Aug; 21(8):1658-68. PubMed ID: 17541402
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer.
Hanawa S; Mitsuhashi A; Shozu M
PLoS One; 2018; 13(2):e0192759. PubMed ID: 29444159
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart.
Little SC; Curran J; Makara MA; Kline CF; Ho HT; Xu Z; Wu X; Polina I; Musa H; Meadows AM; Carnes CA; Biesiadecki BJ; Davis JP; Weisleder N; Györke S; Wehrens XH; Hund TJ; Mohler PJ
Sci Signal; 2015 Jul; 8(386):ra72. PubMed ID: 26198358
[TBL] [Abstract][Full Text] [Related]
19. CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients.
Pardanani A; Lasho T; Smith G; Burns CJ; Fantino E; Tefferi A
Leukemia; 2009 Aug; 23(8):1441-5. PubMed ID: 19295546
[TBL] [Abstract][Full Text] [Related]
20. Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling.
Li M; Zhao L; Liu J; Liu A; Jia C; Ma D; Jiang Y; Bai X
Cell Signal; 2010 Oct; 22(10):1469-76. PubMed ID: 20639120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
